Loading...
•
Dec 31, 2025
QIAGEN Q4 2025 Earnings Report
QIAGEN exceeded its outlook in the fourth quarter driven by growth pillars and improved profitability.
Key Takeaways
QIAGEN delivered Q4 2025 results above its outlook with modest sales growth and stronger adjusted earnings, supported by growth pillars and operating discipline.
Q4 net sales reached $540 million, exceeding outlook
Adjusted diluted EPS of $0.62 surpassed expectations
Growth pillars delivered solid performance despite macro headwinds
Adjusted operating margin improved year over year
Forward Guidance
QIAGEN expects continued growth in 2026 driven by its growth pillars and operating leverage.
Positive Outlook
- Growth pillars expected to accelerate sales
- Improving operating leverage
- Strong adjusted profitability trend
- Disciplined capital allocation
- Positive adjusted EPS outlook
Challenges Ahead
- Macroeconomic uncertainty
- Currency headwinds
- Tariff-related pressures
- Integration risk from acquisitions
- Public sector funding variability
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...